Prognostic value of measurable residual disease after venetoclax and decitabine in acute myeloid leukemia

Research output: Contribution to journalArticlepeer-review

66 Scopus citations

Fingerprint

Dive into the research topics of 'Prognostic value of measurable residual disease after venetoclax and decitabine in acute myeloid leukemia'. Together they form a unique fingerprint.

Keyphrases

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science